The LumiraDx Platform is an innovative, next generation point of care diagnostic system that combines a small, portable instrument, advanced low-cost test strip and seamless digital connectivity.
FEATURES
SIMPLE AND PATIENT FRIENDLY
Easy and intuitive to use, requiring only basic training:
Step-by-step guidance provided on screen
Simple, intuitive touchscreen
Small samples, including capillary
The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point-of-care.
Test Benefits
The use of
